Pages that link to "Q28259736"
Jump to navigation
Jump to search
The following pages link to Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial (Q28259736):
Displaying 50 items.
- Atypical antipsychotics in bipolar disorder: systematic review of randomised trials (Q21260276) (← links)
- Bipolar Disorder: An Update (Q22241210) (← links)
- Olanzapine in long-term treatment for bipolar disorder (Q24241099) (← links)
- A critical appraisal of treatments for bipolar disorder (Q24613657) (← links)
- Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder (Q24643545) (← links)
- Review of olanzapine in the management of bipolar disorders (Q24657398) (← links)
- Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012 (Q26824955) (← links)
- A decision analysis of long-term lithium treatment and the risk of renal failure (Q27004676) (← links)
- The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm (Q28066714) (← links)
- Neurological complications of psychiatric drugs: clinical features and management (Q28262051) (← links)
- (Q28281197) (← links)
- Bipolar disorder. (Q33448290) (← links)
- The psychopathology and treatment of bipolar disorder (Q33619910) (← links)
- Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study. (Q33673618) (← links)
- Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention (Q33820164) (← links)
- Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials (Q34197988) (← links)
- Maintenance therapies in bipolar disorders (Q34268760) (← links)
- Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis (Q34349641) (← links)
- Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study (Q34389967) (← links)
- Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients (Q34504598) (← links)
- Adverse effects of atypical antipsychotics : differential risk and clinical implications (Q34583643) (← links)
- Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. (Q34634154) (← links)
- Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder (Q34645789) (← links)
- The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder (Q34649187) (← links)
- Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology (Q34676317) (← links)
- Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis (Q34744822) (← links)
- Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis (Q35007923) (← links)
- Acute and long-term treatment of mania. (Q35236966) (← links)
- Use of a relapse monitoring board: an independent assessment for determining relapse in clinical trials for bipolar disorder. (Q35575996) (← links)
- Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines. (Q35822006) (← links)
- The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review (Q35858926) (← links)
- Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder (Q35930169) (← links)
- Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder (Q36162402) (← links)
- Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder (Q36248072) (← links)
- Identifying and improving non-adherence in bipolar disorders. (Q36286408) (← links)
- Pharmacological treatment of mixed states (Q36349023) (← links)
- Polytherapy in bipolar disorder (Q36361982) (← links)
- Pharmacological treatment in the early phase of bipolar disorders: what stage are we at? (Q36395731) (← links)
- Olanzapine - relapse prevention following mania (Q36427635) (← links)
- A review of the evidence for the use of antipsychotics in the maintenance treatment of bipolar disorders (Q36427639) (← links)
- Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis (Q36433993) (← links)
- Long-term prophylaxis in bipolar disorder. (Q36442327) (← links)
- The role of quetiapine in the treatment of bipolar disorder (Q36458469) (← links)
- Long-term use of atypical antipsychotics in bipolar disorder (Q36545075) (← links)
- Cost effectiveness of olanzapine in prevention of affective episodes in bipolar disorder in the United Kingdom (Q36627983) (← links)
- Emerging drugs for bipolar disorder (Q36634257) (← links)
- Evolving trends in the long-term treatment of bipolar disorder (Q36762209) (← links)
- Atypical antipsychotics for the treatment of bipolar disorder: more shadows than lights (Q36797200) (← links)
- Epidemiology, diagnosis and management of mixed mania (Q36881398) (← links)
- Depot antipsychotic medications in bipolar disorder: a review of the literature (Q36905876) (← links)